Effect of pregnancy and exogenous ovarian steroids on endometrial prolactin receptor ontogeny and uterine secretory response in pigs.
During gestation, pigs have constant circulating levels of prolactin (PRL), and lack decidual PRL and placental lactogens. Effects of PRL on uterine physiology in pigs may be due to changes in endometrial PRL receptors. In this study, effects of the conceptus and cyclic hormonal environment on endometrial PRL receptors were investigated. Endometrial PRL receptor numbers were similar between Days 8 and 15 for cyclic gilts. In contrast, endometrial PRL receptor numbers for pregnant gilts were similar between Days 8 and 11, then increased (p less than 0.05) on Day 12 and remained elevated between Days 14 and 30. This day-by-status interaction approached significance (p less than 0.06) and overall receptor numbers were higher (p less than 0.01) for pregnant than for cyclic gilts. Pig conceptuses secrete estrogen between Days 11 and 12; therefore, regulation of endometrial PRL receptors by acute administration of estradiol was investigated. Uterine flushings and endometrium were collected from one uterine horn of cyclic gilts on Day 11; then, at 1, 6, 12, and 24 h following a single injection of estradiol valerate (EV; 5 mg, into adipose tissue), uterine flushings and endometrium were collected from the second uterine horn. Endometrial PRL receptor numbers were higher (p less than 0.05) at both 1 h and 6 h after treatment with EV and then decreased (p less than 0.02) by 12 h to below pretreatment values. In uterine flushings, total recoverable protein (p less than 0.05), uteroferrin (p less than 0.01), leucine aminopeptidase (p less than 0.05), calcium (p less than 0.03), sodium (p less than 0.01), and potassium (p less than 0.05) increased between 12 and 24 h following EV treatment.(ABSTRACT TRUNCATED AT 250 WORDS)
Young
K H
KH
Animal Science Department, University of Florida, Gainesville 32611.
Kraeling
R R
RR
Bazer
F W
FW
D000818:Animals; D004338:Drug Combinations; D004717:Endometrium / Q000737:chemistry / Q000648:ultrastructure*; D004958:Estradiol / Q000008:administration & dosage / Q000494:pharmacology*; D004967:Estrogens / Q000378:metabolism; D004971:Estrus / Q000502:physiology; D005260:Female; D007267:Injections; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000502:physiology*; D011374:Progesterone / Q000008:administration & dosage / Q000494:pharmacology*; D011981:Receptors, Prolactin / Q000032:analysis / Q000187:drug effects* / Q000502:physiology; D012098:Reproduction / Q000187:drug effects / Q000502:physiology; D013552:Swine / Q000502:physiology*; D014599:Uterus / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology
D004338:Drug Combinations; D004967:Estrogens; D011981:Receptors, Prolactin; D011374:Progesterone; D004958:Estradiol